These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2790333

  • 1. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation.
    Rowley SD, Piantadosi S, Santos GW.
    Bone Marrow Transplant; 1989 Sep; 4(5):553-8. PubMed ID: 2790333
    [Abstract] [Full Text] [Related]

  • 2. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
    Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM.
    Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
    [Abstract] [Full Text] [Related]

  • 3. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A, Stachowiak J, Giarratana MC, Baillou C, Salmon C.
    Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
    [Abstract] [Full Text] [Related]

  • 4. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS, Gremba C, Shadduck RK, Zeigler ZR, Nemunaitis J.
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [Abstract] [Full Text] [Related]

  • 5. Long-term cryopreservation of bone marrow for autologous transplantation.
    Attarian H, Feng Z, Buckner CD, MacLeod B, Rowley SD.
    Bone Marrow Transplant; 1996 Mar; 17(3):425-30. PubMed ID: 8704699
    [Abstract] [Full Text] [Related]

  • 6. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation.
    Stewart FM, Kaiser DL, Ishitani KP, Pirsch GW, Niskanen E.
    Exp Hematol; 1989 Oct; 17(9):974-80. PubMed ID: 2673831
    [Abstract] [Full Text] [Related]

  • 7. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow.
    Rowley SD, Zuehlsdorf M, Braine HG, Colvin OM, Davis J, Jones RJ, Saral R, Sensenbrenner LL, Yeager A, Santos GW.
    Blood; 1987 Jul; 70(1):271-5. PubMed ID: 3297203
    [Abstract] [Full Text] [Related]

  • 8. Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children.
    Emminger W, Emminger-Schmidmeier W, Höcker P, Hinterberger W, Gadner H.
    Bone Marrow Transplant; 1989 Jul; 4(4):415-20. PubMed ID: 2673462
    [Abstract] [Full Text] [Related]

  • 9. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation].
    Mayer J, Korístek Z, Pospísil Z, Vásová I, Adam Z, Hájek R, Krejcí M, Král Z, Navrátil M, Vorlícek J, Bourková L, Matýsková M, Adler J, Vinklárková J, Klabusay M, Koutná I, Hoffová V, Schmitzová D, Janovská E.
    Cas Lek Cesk; 1999 Mar 15; 138(6):170-7. PubMed ID: 10510531
    [Abstract] [Full Text] [Related]

  • 10. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L, Laporte JP, Mary JY, Lopez M, Lemonnier MP, Stachowiak J, Benitez O, Deloux J, Najman A, Salmon C.
    Bone Marrow Transplant; 1987 Jun 15; 2(1):33-43. PubMed ID: 3332155
    [Abstract] [Full Text] [Related]

  • 11. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation.
    Bacigalupo A, Piaggio G, Podesta M, Figari O, Benvenuto F, Sogno G, Tedone E, Raffo MR, Grassia L, Ferrero R.
    Bone Marrow Transplant; 1995 Feb 15; 15(2):221-6. PubMed ID: 7773210
    [Abstract] [Full Text] [Related]

  • 12. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
    Douay L, Lopez M, Gorin NC, Nauman A, Giarratana MC, Laporte JP, Stachowiak J, Salmon C, Duhamel G.
    Int J Cell Cloning; 1986 Jul 15; 4(4):250-62. PubMed ID: 2875118
    [Abstract] [Full Text] [Related]

  • 13. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A, Kawano Y, Takaue Y, Suzue T, Abe T, Sato J, Saito S, Okamoto Y, Makimoto A, Kawahito M.
    Exp Hematol; 1994 Jun 15; 22(6):521-6. PubMed ID: 8187849
    [Abstract] [Full Text] [Related]

  • 14. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y, Harada M, Teshima T, Makino S, Inaba S, Akashi K, Shibuya T, Niho Y.
    Exp Hematol; 1995 Jan 15; 23(1):8-13. PubMed ID: 7527786
    [Abstract] [Full Text] [Related]

  • 15. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E, Burroughs J, DeFor T, Verfaillie C, Weisdorf D.
    Bone Marrow Transplant; 2003 Sep 15; 32(6):575-80. PubMed ID: 12953129
    [Abstract] [Full Text] [Related]

  • 16. Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts.
    Rowley S, Davis J, Braine H, Jones R, Yeager A, Saral R, Santos G.
    Prog Clin Biol Res; 1990 Sep 15; 333():369-77. PubMed ID: 2308991
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar 15; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 18. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA, Brecher ME, Powell E, Serody JS, Wiley JM, Shea TC.
    Bone Marrow Transplant; 1997 Mar 15; 19(6):557-63. PubMed ID: 9085735
    [Abstract] [Full Text] [Related]

  • 19. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N, Mohamed R.
    Exp Hematol; 1995 Dec 15; 23(14):1661-6. PubMed ID: 8542962
    [Abstract] [Full Text] [Related]

  • 20. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients.
    Yoo KH, Lee SH, Kim HJ, Sung KW, Jung HL, Cho EJ, Park HK, Kim HA, Koo HH.
    Bone Marrow Transplant; 2007 May 15; 39(9):515-21. PubMed ID: 17334379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.